Frankfurt - Delayed Quote EUR
Champions Oncology, Inc. (2I3.F)
5.15
0.00
(0.00%)
As of May 2 at 3:29:01 PM GMT+2. Market Open.
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
58,591
50,155
53,870
49,109
41,040
Cost of Revenue
28,368
29,401
29,532
23,632
21,446
Gross Profit
30,223
20,754
24,338
25,477
19,594
Operating Expense
23,499
27,675
28,787
24,870
19,228
Operating Income
6,724
-6,921
-4,449
607
366
Other Income Expense
-324
-387
-818
-24
71
Pretax Income
6,400
-7,308
-5,267
583
437
Tax Provision
-27
-32
68
35
75
Net Income Common Stockholders
6,427
-7,276
-5,335
548
362
Diluted NI Available to Com Stockholders
6,427
-7,276
-5,335
548
362
Basic EPS
0.47
-0.54
-0.39
0.04
0.03
Diluted EPS
0.45
-0.54
-0.39
0.04
0.02
Basic Average Shares
13,609.26
13,547.60
13,541.56
13,197.17
13,139
Diluted Average Shares
13,993.28
13,547.60
13,541.56
14,159.80
14,573.56
Total Operating Income as Reported
6,289
-7,356
-5,256
607
366
Total Expenses
51,867
57,076
58,319
48,502
40,674
Net Income from Continuing & Discontinued Operation
6,427
-7,276
-5,335
548
362
Normalized Income
6,688
-6,843.18
-4,697.47
548
362
EBIT
6,724
-6,921
-4,449
607
366
EBITDA
8,427
-5,054
-2,203
2,234
1,550
Reconciled Cost of Revenue
28,368
29,401
29,532
23,632
21,446
Reconciled Depreciation
1,703
1,867
2,246
1,627
1,184
Net Income from Continuing Operation Net Minority Interest
6,427
-7,276
-5,335
548
362
Total Unusual Items Excluding Goodwill
-435
-435
-807
--
--
Total Unusual Items
-435
-435
-807
--
--
Normalized EBITDA
8,862
-4,619
-1,396
2,234
1,550
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-174
-2.18
-169.47
--
--
4/30/2021 - 5/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade